ArticleACS chemical neuroscience2019

Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA.

David B Finlay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.